Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

19. HIV/AIDS and Substance Use Disorders 431cytochemical quantitation of HIV in the brain: Correlations with HIV-associateddementia. Ann Neurol, 38, 755–762.Glass, R. M. (1988). AIDS and suicide [Editorial]. JAMA, 259, 1369–1370.Glenn, S. W., & Parsons, O. A. (1992). Neuropsychological efficiency measures in maleand female alcoholics. J Stud Alcohol, 53, 546–552.Golub, E. T., Astemborski, J. A., Hoover, D. R., Anthony, J. C., Vlahov, D., &Strathdee, S. A. (2003). Psychological distress and progression to AIDS in acohort of injection drug users. J Acquir Immune Defic Syndr, 32, 429–434.Goodkin, K., Mulder, C. L., Blaney, N. T., Ironson, G., Kumar, M., & Fletcher, M. A.(1994). Psychoneuroimmunology and human immunodeficiency virus type 1infection revisited. Arch Gen Psychiatry, 51, 246–247.Gostin, L. O., Lazzarini, S., Jones, S., & Flaherty, K. (1997). Prevention of HIV/AIDSand other blood-borne diseases among injection drug users. JAMA, 277, 53–62.Govitrapong, P., Suttitum, T., Kotchabhakdi, N. & Uneklabh, T. (1998). Alterationsof immune functions in heroin addicts and heroin withdrawal subjects. J PharmacolExp Ther, 286, 883–889.Grant, I., & Reed, R. (1985). Neuropsychology of alcohol and drug abuse. In A. I.Alterman (Ed.), Substance abuse and psychopathology (pp. 289–341). New York:Plenum Press.Health Insurance Portability and Accountability Act. (2003). Office for Civil Rights.Washington, DC: Department of Health and Human Services. Retrieved December,27, 2003, from www.hhs.gov/ocr/hipaaHoffman, J. A., Klein, H., Eber, M., & Crosby, H. (2000). Frequency and intensity ofcrack use. Drug Alcohol Depend, 58, 227–236.Holtzman, D. M., Kaku, D. A., & So, Y. T. (1989). New onset seizures associated withhuman immunodeficiency virus infection: Causation and clinical features in 100cases. Am J Med, 87, 173–180.Irwin, M., Caldwell, C., Smith, T. L., Brown, S., Schuckit, M. A., & Gillin, J. C.(1990). Major depressive disorder, alcoholism, and reduced natural killer cellcytotoxicity. Arch Gen Psychiatry, 47, 713–719.Janssen, R. S., Nwanyanwu, O. C., Selik, R. M., & Stehr-Green, J. K. (1992). Epidemiologyof human immunodeficiency virus encephalopathy in the United States.Neurology, 42, 1472–1476.Johnson, T. R., Knisely, J. S., Christmas, J. T., Schnoll, S. H., & Ruddy, S. (1996).Changes in immunologic cell surface markers during cocaine withdrawal in pregnantwomen. Brain Behav Immun, 10, 324–336.Kennedy, C. A., & Eckholdt, H. M. (1997). Diagnosis of AIDS in U.S. adolescents:1983–1993. In L. Sherr (Ed.), AIDS and adolescents (pp. 51–61). London: HarwoodAcademic.Kennedy, C. A., & Hill, J. M. (1997, March). Barriers to advance directives in hospitalizedAIDS patients. Paper presented at the annual meeting of the American PsychosomaticAssociation, Santa Fe, NM.Kennedy, C. A., Skurnick, J. H., Foley, M., & Louria, D. (1995). Gender differences inHIV-related psychological distress in heterosexual couples. AIDS Care, 7, S33–S38.Kennedy, C. A., Skurnick, J. H., & Lintott, M. (1994, May). Evaluation of factors related